As part of the company’s increased clinical focus, NanoEcho, Ulrika Axelsson and Kristina Hallström participated in the 11th Annual Outsourcing in Clinical Trials Nordics 2023 in Copenhagen.
“Having the opportunity to network with colleagues in the industry and stay up-to-date on the latest in the design and implementation of clinical studies gives us valuable input in our continued work to prepare the clinical registration study,” says Ulrika Axelsson, clinical director at NanoEcho.
NanoEcho’s innovative method, with its high precision, aims to facilitate the differentiation between diseased and healthy tissue and at the same time determine a more precise localization of cancerous tissue. The goal is to provide a more reliable diagnosis of, for example cancer diseases, that has the potential to contribute to cost-effectiveness in the health care.
We use cookies to enhance your experience on our website and analyze our traffic. By clicking ‘Accept,’ you consent to our use of cookies. You can learn more about the types of cookies we use and how to manage them in our privacy policy.